661
Views
29
CrossRef citations to date
0
Altmetric
Articles

Ambulatory Blood Pressure Monitoring for the Early Identification of Hypertension in Pregnancy

&
Pages 233-259 | Received 04 Jul 2012, Accepted 12 Jul 2012, Published online: 24 Sep 2012

REFERENCES

  • Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARIS Collaborative Group. (2007). Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369:1791e–1798.
  • Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH. (2007). Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study. J. Hypertens. 25:2479–2485.
  • Ayala DE, Hermida RC. (1993). Circadian time structure of cardiovascular characteristics in human pregnancy. Chronobiol. Int. 10:128–136.
  • Ayala DE, Hermida RC. (1995). Multifrequency infradian variation of blood pressure during and after human pregnancy. Chronobiol. Int. 12:333–344.
  • Ayala DE, Hermida RC. (2001). Influence of parity and age on ambulatory monitored blood pressure during pregnancy. Hypertension 38:753–758.
  • Ayala DE, Hermida RC, Mojón A, Fernández JR, Iglesias M. (1997a). Circadian blood pressure variability in healthy and complicated pregnancies. Hypertension 30:603–610.
  • Ayala DE, Hermida RC, Mojón A, Fernández JR, Silva I, Ucieda R, Iglesias M. (1997b). Blood pressure variability during gestation in healthy and complicated pregnancies. Hypertension 30:611–618.
  • Ayala DE, Hermida RC, Mojón A, Fernández JR. (2013a). Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol. Int. 30:340–352.
  • Ayala DE, Ucieda R, Hermida RC. (2013b). Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol. Int. 30: 260–279.
  • Beilin LJ, Deacon J, Michael CA, Vandongen R, Lalor CM, Barden AE, Davidson L. (1982). Circadian rhythms of blood pressure and pressor hormones in normal and hypertensive pregnancy. Clin. Exp. Pharmacol. Physiol. 9:321–326.
  • Bellomo G, Rondoni F, Pastorelli G, Stangoni G, Narducci P, Angeli G. (1995). Twenty four-hour ambulatory blood pressure monitoring in women with pre-eclampsia. J. Hum. Hypertens. 9:617–621.
  • Bellomo G, Narducci PL, Rondoni F, Pastorelli G, Stangoni G, Angeli G, Verdecchia P. (1999). Prognostic value of 24-hour blood pressure in pregnancy. JAMA 282:1447–1452.
  • Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. (2007). Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49:1235–1241.
  • Ben-Dov IZ, Mekler J, Bursztyn M. (2008). Sex differences in ambulatory blood pressure monitoring. Am. J. Med. 121:509–514.
  • Benedetto C, Zonca M, Marozio L, Dolco C, Carandente F, Massobrio M. (1996). Blood pressure patterns in normal pregnancy and in pregnancy-induced hypertension, preeclampsia, and chronic hypertension. Obstet. Gynecol. 88:503–510.
  • Benedetto C, Marozio L, Giarola M, Chiarolini L, Maulà V, Massobrio M. (1998). Twenty-four hour blood pressure monitoring in early pregnancy: is it predictive of pregnancy-induced hypertension and preeclampsia? Acta Obstet. Gynecol. Scand. 77:14–21.
  • Blanco-García R, Novoa-Fernández E, Borrajo-Prol MP, Camba-Caride MJ, Varillas C, Otero A, Hermida RC. (2007). Indice hiperbárico en embarazadas. Necesidad de definir un perfil clínico de riesgo. Hipertensión 24(Extraordinario 2):165.
  • Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA. (2007). Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370:1219–1229.
  • Bouhanick B, Bongard V, Amar J, Bousquel S, Chamontin B. (2008). Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab. 34:560–567.
  • Brotman DJ, Davidson MB, Boumitri M, Vidt DG. (2008). Impaired diurnal blood pressure variation and all-cause mortality. Am. J. Hypertens. 21:92–97.
  • Brown MA, Robinson A, Bowyer L, Buddle ML, Martin A, Hargood JL, Cario GM. (1998). Ambulatory blood pressure monitoring in pregnancy: what is normal? Am. J. Obstet. Gynecol. 178:836–842.
  • Brown MA, Bowyer L, McHugh L, Davis GK, Mangos GJ, Jones M. (2001a). Twenty-four-hour automated blood pressure monitoring as a predictor of preeclampsia. Am. J. Obstet. Gynecol. 185:618–622.
  • Brown MA, Davis GK, McHugh L. (2001b). The prevalence and clinical significance of nocturnal hypertension in pregnancy. J. Hypertens. 19:1437–1444.
  • Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. (2001c). The classification and diagnosis of the hypertensive disorders of pregnancy: statement from The International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens. Pregnancy 20:ix–xiv.
  • Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD, Klebanoff M, Vandorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G, National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. (2002). Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am. J. Obstet. Gynecol. 186:66–71
  • Burt VL. Whelton P. Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. (1995). Prevalence of hypertension in the US adult population: results of the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 25:305–313.
  • Carandente F, Angeli A, Massobrio M, Dolci C, Barattini P, Terzolo M, Melzi E, Benedetto C. (1990). Blood pressure and heart rate in pregnancy: comparison between health and pathologic conditions. Prog. Clin. Biol. Res. 341A:575–584.
  • Chesley LC, Sibai BM. (1988). Clinical significance of elevated mean arterial pressure in the second trimester. Am. J. Obstet. Gynecol. 159:275–279.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Rocella EJ, and the National High Blood Pressure Education Coordinating Committee. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289:2560–2571.
  • Churchill D, Perry IJ, Beevers DG. (1997). Ambulatory blood pressure in pregnancy and fetal growth. Lancet 349:7–10.
  • Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E. (2003). Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N. Engl. J. Med. 348:2407–2415.
  • Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. (2004). Maternal and fetal genetic factors account for most of familial aggregation of pre-eclampsia: a population-based Swedish cohort study. Am. J. Med. Genet. A 130A:365–371.
  • Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, Zwinderman AH, Robson SC, Bindels PJ, Kleijnen J, Khan KS. (2008a). Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 178:701–711.
  • Cnossen JS, Vollebregt KC, de Vrieze N, ter Riet G, Mol BW, Franx A, Khan KS, van der Post JA. (2008b). Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis. BMJ 336:1117–1120.
  • Cnossen JS, ter Riet G, Mol BW, van der Post JA, Leeflang MM, Meads CA, Hyde C, Khan KS. (2009). Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet. Gynecol. Scand. 88:758–765.
  • Contard S, Chanudet X, Coisne D, Battistella P, Marichal JF, Pitiot M, Gaudemaris R, Ribstein J. (1993). Ambulatory monitoring of blood pressure in normal pregnancy. Am. J. Hypertens. 6:880–884.
  • Cornélissen G, Kopher R, Brat P, Rigatuso J, Work B, Eggen D, Einzig S, Vernier R, Halberg F. (1989). Chronobiologic ambulatory cardiovascular monitoring during pregnancy in Group Health of Minnesota. In Proceedings of the 2nd Annual IEEE Symposium on Computer-Based Medical Systems, Minneapolis, MN, June 26–27, 1989. pp. 226–237.
  • Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. (2005). Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 352:2477–2486.
  • Cugini P, Di Palma L, Battisti P, Leone G, Pachi A, Paesano R, Masella C, Stirati G, Pierucci A, Rocca AR. (1992). Describing and interpreting 24-hour blood pressure patterns in physiologic pregnancy. Am. J. Obstet. Gynecol. 166:54–60.
  • Davey DA, MacGillivray I. (1988). The classification and definition of the hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 158:892–898.
  • Dekker GA, Sibai BM. (1991). Early detection of preeclampsia. Am. J. Obstet. Gynecol. 165:160–172.
  • Dekker GA, Sibai BM. (1993). Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials. Am. J. Obstet. Gynecol. 168:214–227.
  • Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46:156–161.
  • Duckitt K, Harrington D. (2005). Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330:565.
  • Duley L. (2009). The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 33:130–137.
  • Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz J, Shimada K, Kario K. (2008). Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am. J. Hypertens. 21:443–450.
  • Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi F. (2013). Dipper and non-dipper blood pressure 24 hour patterns: Circadian rhythm–dependent physiologic and pathophysiologic mechanisms. Chronobiol. Int. 30:17–30.
  • Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. (2008). Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51:55–61.
  • Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Björklund-Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O'Brien E, Wang J, Staessen JA. (2010). Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J. Hypertens. 28:2036–2045.
  • Ferguson JH, Neubauer BL, Shaar CJ. (1994). Ambulatory blood pressure monitoring during pregnancy. Establishment of standards of normalcy. Am. J. Hypertens. 7:838–843.
  • Fernández JR, Hermida RC. (1998). Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol. Int. 15:191–204.
  • Fernández JR, Hermida RC. (2000). Computation of model-dependent tolerance bands for ambulatorily monitored blood pressure. Chronobiol. Int. 17:567–582.
  • Fernández JR, Mojón A, Hermida RC. (2004). Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol. Int. 21:467–482.
  • Friedman SA. (1988). Preeclampsia: a review of the role of prostaglandins. Obstet. Gynecol. 71:122–137.
  • Gallerani M, Portaluppi F, Grandi E, Manfredini R. (1997). Circadian rhythmicity in the occurrence of spontaneous acute dissection and rupture of thoracic aorta. J. Thorac. Cardiovasc. Surg. 113:603–604.
  • Gallery ED, Hunyor SN, Ross M, Gyory AZ. (1977). Predicting the development of pregnancy associated hypertension: the place of standardised blood pressure measurement. Lancet 1:1273–1275.
  • Gosse P, Lasserre R, Minifié C, Lemetayer P, Clementy J. (2004). Blood pressure on rising. J. Hypertens. 22:1113–1118.
  • Halberg F, Ahlgren A, Haus E. (1984). Circadian systolic and diastolic hyperbaric indices of high school and college students. Chronobiologia 11:299–309.
  • Halberg E, Delmore P, Finch M, Cornélissen G, Halberg F. (1990). Chronobiologic assessment of deviant human blood pressure: an invitation for improvements. In Hayes DK, Pauly JE, Reiter RJ(eds.). Chronobiology: its role in clinical medicine, general biology, and agriculture, part A. New York: Wiley-Liss, 305–318.
  • Halligan A, O'Brien E, O'Malley K, Mee F, Atkins N, Conroy R, Walshe JJ, Darling M. (1993). Twenty-four-hour ambulatory blood pressure measurement in a primigravid population. J. Hypertens. 11:869–873.
  • Hermida RC. (1999). Time-qualified reference values for 24 h ambulatory blood pressure monitoring. Blood Press. Monit. 4:137–147.
  • Hermida RC, Ayala DE. (1997). Diagnosing gestational hypertension and preeclampsia with the 24-hour mean of blood pressure. Hypertension 30:1531–1537.
  • Hermida RC, Ayala DE. (2001). Evaluation of the blood pressure load in the diagnosis of hypertension in pregnancy. Hypertension 38:723–729.
  • Hermida RC, Ayala DE. (2002). Prognostic value of office and ambulatory blood pressure measurements in pregnancy. Hypertension 40:298–303.
  • Hermida RC, Ayala DE. (2003). Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy. Hypertension 42:619–624.
  • Hermida RC, Ayala DE. (2004). Prognostic value of ambulatory blood pressure measurements for the diagnosis of hypertension in pregnancy. Expert Rev. Cardiovasc. Ther. 2:89–105.
  • Hermida RC, Ayala DE. (2005a). Reference thresholds for 24-hour, diurnal, and nocturnal blood pressure mean values in pregnancy. Blood Press. Monit. 10:33–41.
  • Hermida RC, Ayala DE. (2005b). Circadian blood pressure variability in normotensive pregnant women as a function of parity, maternal age, and stage of gestation. Chronobiol. Int. 22:321–341.
  • Hermida RC, Ayala DE. (2010). Prognostic value of ambulatory blood pressure monitoring in pregnancy. J. Hypertens. 28:1110–1111.
  • Hermida RC, Fernández JR. (1996). Computation of time-specified tolerance intervals for ambulatorily monitored blood pressure. Biomed. Instrum. Technol. 30:257–266.
  • Hermida RC, Mojón A, Fernández JR, Ayala DE. (1996). Computer-based medical system for the computation of blood pressure excess in the diagnosis of hypertension. Biomed. Instrum. Technol. 30:267–283.
  • Hermida RC, Ayala DE, Iglesias M, Mojón A, Silva I, Ucieda R, Fernández JR. (1997a). Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension 30:589–595.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR, Silva I, Ucieda R, Iglesias M. (1997b). High sensitivity test for the early diagnosis of gestational hypertension and preeclampsia. I. Predictable variability of cardiovascular characteristics during gestation in healthy and hypertensive pregnant women. J. Perinat. Med. 25:101–109.
  • Hermida RC, Ayala DE, Mojón A, Iglesias M. (1997c). High sensitivity test for the early diagnosis of gestational hypertension and preeclampsia. II. Circadian blood pressure variability in healthy and hypertensive pregnant women. J. Perinat. Med. 25:153–167.
  • Hermida RC, Fernández JR, Mojón A. (1997d). High sensitivity test for the early diagnosis of gestational hypertension and preeclampsia. III. Computation of time-specified tolerance intervals as reference for blood pressure excess in the diagnosis of gestational hypertension. J. Perinat. Med. 25:237–253.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR, Silva I, Ucieda R, Iglesias M. (1997e). High sensitivity test for the early diagnosis of gestational hypertension and preeclampsia. IV. Early detection of gestational hypertension and preeclampsia by the computation of a hyperbaric index. J. Perinat. Med. 25:254–273.
  • Hermida RC, Fernández JR, Alonso I, Ayala DE, García L. (1997f). Computation of time-specified tolerance intervals for hybrid time series with nonequidistant sampling, illustrated for plasma growth hormone. Chronobiol. Int. 14:409–425.
  • Hermida RC, Mojón A, Fernández JR, Ayala DE. (1997g). The tolerance-hyperbaric test for hypertension diagnosis. Biomed. Instrum. Technol. 31:499–510.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR, Silva I, Ucieda R, Iglesias M. (1998). Blood pressure excess for the early identification of gestational hypertension and preeclampsia. Hypertension 31:83–89.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Silva I, Ucieda R, Codesido J, Iglesias M. (1999). Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. Hypertension 34:1016–1023.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR, Alonso I, Silva I, Ucieda R, Iglesias M. (2000a). Blood pressure patterns in normal pregnancy, gestational hypertension and preeclampsia. Hypertension 36:149–158.
  • Hermida RC, Fernández JR, Mojón A, Ayala DE. (2000b). Reproducibility of the hyperbaric index as a measure of blood pressure excess. Hypertension 35:118–125.
  • Hermida RC, Ayala DE, Iglesias M. (2001a). Predictable blood pressure variability in healthy and complicated pregnancies. Hypertension 38:736–741.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2001b). Time-qualified reference values for ambulatory blood pressure monitoring in pregnancy. Hypertension 38:746–752.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Calvo C. (2002a). Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol. Int. 19:461–481.
  • Hermida RC, Calvo C, Ayala DE, Fernández JR, Ruilope LM, López JE. (2002b). Evaluation of the extent and duration of the “ABPM effect” in hypertensive patients. J. Am. Coll. Cardiol. 40:710–717.
  • Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. (2002c). Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 20:1097–1104.
  • Hermida RC, Mojón A, Fernández JR, Alonso I, Ayala DE. (2002d). The tolerance-hyperbaric test: a chronobiologic approach for improved diagnosis of hypertension. Chronobiol. Int. 19:1183–1211.
  • Hermida RC, Ayala DE, Iglesias M. (2003a). Circadian rhythm of blood pressure challengues office values as the “gold standard” in the diagnosis of gestational hypertension. Chronobiol. Int. 20:135–156.
  • Hermida RC, Ayala DE, Iglesias M. (2003b). Administration-time dependent influence of aspirin on blood pressure in pregnant women. Hypertension 41:651–656.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR, Alonso I, Aguilar MF, Ucieda R, Iglesias M. (2003c). Differences in circadian blood pressure variability during gestation between healthy and complicated pregnancies. Am. J. Hypertens. 16:200–208.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A, Iglesias M. (2004a). Reproducibility of the tolerance-hyperbaric test for diagnosing hypertension in pregnancy. J. Hypertens. 22:565–572.
  • Hermida RC, Ayala DE, Iglesias M. (2004b). Circadian blood pressure variability as a function of parity in normotensive pregnant women. J. Clin. Hypertens. 6:126–133.
  • Hermida RC, Ayala DE, Iglesias M. (2004c). Differences in circadian pattern of ambulatory pulse pressure between healthy and complicated pregnancies. Hypertension 44:316–321.
  • Hermida RC, Fernández JR, Ayala DE, Mojón A, Alonso I, Calvo C. (2004d). Circadian time-qualified tolerance intervals for ambulatory blood pressure monitoring in the diagnosis of hypertension. Chronobiol. Int. 21:149–170.
  • Hermida RC, Ayala DE. Fernandez JR, Mojón A, Calvo C. (2007a). Influence of measurement duration and frequency on ambulatory blood pressure monitoring. Rev. Esp. Cardiol. 60:131–138.
  • Hermida RC, Ayala DE, Portaluppi F. (2007b). Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv. Drug Deliv. Rev. 59:904–922.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol. Int. 27:1629–1651.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011a). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J. Am. Coll. Cardiol. 58:1165–1173.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011b). Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34:1270–1276.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011c). Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J. Am. Soc. Nephrol. 22:2313–2321.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012). Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am. J. Hypertens. 25:325–334.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013a). Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol. Int. 30:68–86.
  • Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. (2013b). Ambulatory blood pressure monitoring: importance of sampling rate and duration—48 versus 24 hours—on the accurate assessment of cardiovascular risk. Chronobiol. Int. 30:55–67.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013c). Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level—the “normotensive non-dipper” paradox. Chronobiol Int. 30:87–98.
  • Hermida RC, Ayala DE, Mojón A, Fontao MJ, Chayán L, Fernández JR. (2013d). Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes. Chronobiol. Int. 30:221–232.
  • Hernández-Díaz S, Toh S, Cnattingius S. (2009). Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ 338:b2255.
  • Higashi Y, Nakagawa K, Kimura M, Noma K, Hara K, Sasaki S, Goto C, Oshima T, Chayama K, Yoshizumi M. (2002). Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J. Am. Coll. Cardiol. 40:2039–2043.
  • Higgins JR, Walshe JJ, Halligan A, O'Brien E, Conroy R, Darling MRN. (1997). Can 24-hour ambulatory blood pressure measurement predict the development of hypertension in primigravidae? Br. J. Obstet. Gynaecol. 104:356–362.
  • Hofmeyr GJ, Atallah AN, Duley L. (2006). Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst. Rev. (3):CD001059.
  • Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. (2006). Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 295:2859–2866.
  • Israel S, Israel A, Ben-Dov IZ, Bursztyn M. (2011). The morning blood pressure surge and all-cause mortality in patients referred for ambulatory blood pressure monitoring. Am. J. Hypertens. 24:796–801.
  • Kagan A, Faibel H, Ben-Arie G, Granevitze Z, Rapoport J. (2007). Gender differences in ambulatory blood pressure monitoring profile in obese, overweight and normal subjects. J. Hum. Hypertens. 21:128–134.
  • Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. (2001). Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 38:852–857.
  • Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. (2003). Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 107:1401–1406.
  • Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 45:240–245.
  • Klemmensen AK, Olsen SF, Osterdal ML, Tabor A. (2007). Validity of pre-eclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. Am. J. Epidemiol. 166:117–124.
  • Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, van den Berg PP, de Boer K, Burggraaff JM, Bloemenkamp KW, Drogtrop AP, Franx A, de Groot CJ, Huisjes AJ, Kwee A, van Loon AJ, Lub A, Papatsonis DN, van der Post JA, Roumen FJ, Scheepers HC, Willekes C, Mol BW, van Pampus MG, HYPITAT study group. (2009). Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 374:979–988.
  • Kyle PM, Clark SJ, Buckley D, Kissane J, Coats AJS, De Swiet M, Redman CWG. (1993). Second trimester ambulatory blood pressure in nulliparous pregnancy: a useful screening test for pre-eclampsia? Br. J. Obstet. Gynaecol. 100:914–919.
  • Lawler J, Osman M, Shelton JA, Yeh J. (2007). Population-based analysis of hypertensive disorders in pregnancy. Hypertens. Pregnancy 26:67–76.
  • Lindheimer MD, Taler SJ, Cunningham FG. (2008). Hypertension in pregnancy. J. Am. Soc. Hypertens 2:484–494.
  • Lloyd-Jones DM, Evans JC, Levy D. (2005). Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 294:466–472.
  • MacDorman MF, Declercq E, Zhang J. (2010). Obstetrical intervention and the singleton preterm birth rate in the United States from 1991–2006. Am. J. Public. Health 100:2241–2247.
  • MacGillivray I, Rose GA, Rowe B. (1969). Blood pressure survey in pregnancy. Clin. Sci. 37:395–407.
  • Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HAJ, Zanchetti A. (2007). 2007 guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105–1187.
  • Manfredini R, Gallerani M, Portaluppi F, Fersini C. (1996). Relationships of the circadian rhythms of thrombotic, ischemic, hemorrhagic, and arrhythmic events to blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:141–158.
  • Manfredini R, Fabbian F, Pala M, Tiseo R, De Giorgi A, Manfredini F, Malagoni AM, Signani F, Andreati C, Boari B, Salmi R, Imberti D, Gallerani M. (2011). Seasonal and weekly patterns of occurrence of acute cardiovascular diseases: does a gender difference exist? J. Womens Health 20:1663–1668.
  • Margulies M, Voto LS, Fescina R, Lastra L, Lapidus AM, Schwarcz R. (1987). Arterial blood pressure standards during normal pregnancy and their relation with mother-fetus variables. Am. J. Obstet. Gynecol. 156:1105–1109.
  • Marín R, Gorostidi M, Portal CG, Sánchez M, Sánchez E, Alvarez J. (2000). Long-term prognosis of hypertension in pregnancy. Hypertens. Pregnancy 19:199–209.
  • Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, Roberts TE, Mol BW, van der Post JA, Leeflang MM, Barton PM, Hyde CJ, Gupta JK, Khan KS. (2008). Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol. Assess. 12(6):1–270.
  • Mealing NM, Roberts CL, Ford JB, Simpson JM, Morris JM. (2009). Trends in induction of labour, 1998–2007: a population-based study. Aust. N. Z. J. Obstet. Gynaecol. 49:599–605.
  • Meininger JC, Liehr P, Chan W, Smith G, Mueller WH. (2004). Developmental, gender, and ethnic group differences in moods and ambulatory blood pressure in adolescents. Ann. Behav. Med. 28:10–19.
  • Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2006). Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 47:149–154.
  • Miller RS, Rudra CB, Williams MA. (2007). First-trimester mean arterial pressure and risk of preeclampsia. Am. J. Hypertens. 20:573–578.
  • Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboni P, Conte G, Gabbai FB, De Nicola L. (2011). Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch. Intern. Med. 171:1090–1098.
  • Miyamoto S, Shimokawa H, Sumioki H, Touno A, Nakano H. (1998). Circadian rhythm of plasma atrial natriuretic peptide, aldosterone, and blood pressure during the third trimester in normal and preeclamptic pregnancy. Am. J. Obstet. Gynecol. 158:393–399.
  • Moutquin JM, Rainville C, Giroux L, Raynauld P, Amyot G, Bilodeau R, Pelland N. (1985). A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am. J. Obstet. Gynecol. 151:191–196.
  • Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, Nishizawa M, Kigoshi T, Uchida K. (1998). Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal events in NIDDM subjects. Diabetes 47:1501–1506.
  • Nelson W, Cornélissen G, Hinkley D, Bingham C, Halberg F. (1983). Construction of rhythm-specified reference intervals and regions, with emphasis on ‘hybrid’ data, illustrated for plasma cortisol. Chronobiologia 10:179–193.
  • Nijdam ME, Janssen KJ, Moons KG, Grobbee DE, van der Post JA, Bots ML, Franx A. (2010). Prediction model for hypertension in pregnancy in nulliparous women using information obtained at the first antenatal visit. J. Hypertens. 28:119–126.
  • O'Brien WF. (1990). Predicting pre-eclampsia. Obstet. Gynecol. 75:445–452.
  • O'Brien A, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. (2003). European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J. Hypertens. 21:821–848.
  • Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. (2002). Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20:2183–2189.
  • Öney T, Kaulhausen H. (1983). The value of the mean arterial blood pressure in the second trimester (MAP-2 value) as a predictor of pregnancy-induced hypertension and preeclampsia. A preliminary report. Clin. Exp. Hypertens. B 2:211–216.
  • Ong KL, Tso AW, Lam KS, Cheung BM. (2008). Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension 51:1142–1148.
  • Page EW, Christianson R. (1976). The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am. J. Obstet. Gynecol. 125:740–746.
  • Page NM. (2002). The endocrinology of preeclampsia. Clin. Endocrinol. 57:413–423.
  • Palatini P, Mos L, Santonastaso M, Saladini F, Benetti E, Mormino P, Bortolazzi A, Cozzio S. (2001). Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age. J. Womens. Health (Larchmt) 20:1175–1181.
  • Patterson HR. (1984). Sources of error in recording the blood pressure of patients with hypertension in general practice. BMJ 289:1661–1664.
  • Peek M, Shennan A, Halligan A, Lambert PC, Taylor DJ, De Swiet M. (1996). Hypertension in pregnancy: which method of blood pressure measurement is most predictive of outcome? Obstet. Gynecol. 88:1030–1033.
  • Penny JA, Halligan AWF, Shennan AH, Lambert PC, Jones DR, de Swiet M, Taylor DJ. (1998). Automated, ambulatory, or conventional blood pressure measurement in pregnancy: which is the better predictor of severe hypertension? Am. J. Obstet. Gynecol. 178:521–526.
  • Perloff D, Sokolow M, Cowan R. (1983). The prognostic value of ambulatory blood pressures. JAMA 249:2792–2798.
  • Pickering TG, Gerin W, Schwartz AR. (2002). What is the white-coat effect and how should it be measured? Blood Press. Monit. 7:293–300.
  • Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. (2005). Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans. Hypertension 45:142–161.
  • Pimenta E. (2012). Hypertension in women. Hypertens. Res. 35:148–152.
  • Pinotti M, Bertolucci C, Portaluppi F, Colognesi I, Frigato E, Foa A, Bernardi F. (2005). Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler. Thromb. Vasc. Biol. 25:646–649.
  • Poon LC, Kametas NA, Pandeva I, Valencia C, Nicolaides KH. (2008). Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia. Hypertension 51:1027–1033.
  • Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. (2009). First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 53:812–818.
  • Portaluppi F, Hermida RC. (2007). Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv. Drug Deliv. Rev. 59:940–951.
  • Portaluppi F, Smolensky MH. (2007). Circadian rhythm and environmental determinants of blood pressure regulation in normal and hypertensive conditions. In White WB (ed.). Blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa, NJ: Humana Press, 135–158.
  • Portaluppi F, Smolensky MH. (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652–1667.
  • Portaluppi F, Montanari L, Ferlini M, Gilli P. (1990). Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure. Chronobiol. Int. 7:321–327.
  • Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R, Bagni B, Pansini R, degli Uberti EC. (1992). Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J. Hypertens. 10:1227–1234.
  • Portaluppi F, Cortelli P, Avoni P, Vergnani L, Contin E, Maltoni P, Pavani A, Sforza E, degli Uberti EC, Gambetti P, Lugaresi E. (1994). Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia. Hypertension 23:569–576.
  • Portaluppi F, Vergnani L, Manfredini R, Fersini C. (1996). Endocrine mechanisms of blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:113–131.
  • Portaluppi F, Boari B, Manfredini R. (2004). Oxidative stress in essential hypertension. Curr. Pharm. Des. 10:1695–1698.
  • Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911–1929.
  • Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. (2012). Circadian rhythms and cardiovascular health. Sleep Med. Rev. 16:151–166.
  • Redman CWG, Sargent IL. (2003). Pre-eclampsia, the placenta and the maternal systemic inflammatory response—a review. Placenta ( Suppl A):s21–s27
  • Redman C, Beilin LJ, Bonnar J. (1976). Reversed diurnal blood pressure rhythm in hypertensive pregnancies. Clin. Sci. Mol. Med. 51:687s–689s.
  • Reiss RE, O'Shaughnessy RW, Quilligan TJ, Zuspan FP. (1987). Retrospective comparison of blood pressure course during preeclamptic and matched control pregnancies. Am. J. Obstet. Gynecol. 156:894–898.
  • Roberts CL, Algert CS, Morris JM, Ford JB, Henderson-Smart DJ. (2005). Hypertensive disorders in pregnancy: a population-based study. Med. J. Aust. 182:332–335.
  • Roberts CL, Bell JC, Ford JB, Hadfield RM, Algert CS, Morris JM. (2008). The accuracy of reporting of the hypertensive disorders of pregnancy in population health data. Hypertens. Pregnancy 27:285–297.
  • Roberts CL, Ford JB, Algert CS, Antonsen S, Chalmers J, Cnattingius S, Gokhale M, Kotelchuck M, Melve KK, Langridge A, Morris C, Morris JM, Nassar N, Norman JE, Norrie J, Sorensen HT, Walker R, Weir CJ. (2011). Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open 1:e000101.
  • Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J. (2011). Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 123:e18–e209.
  • Ros HS, Cnattingius S, Lipworth L. (1998). Comparison of risk factors for pre-eclampsia and gestational hypertension in a population-based cohort study. Am. J. Epidemiol. 147:1062–1070.
  • Saftlas AF, Levine RJ, Klebanoff MA, Martz KL, Ewell MG, Morris CD, Sibai BM. (2003). Abortion, changed paternity, and risk of pre-eclampsia in nulliparous women. Am. J. Epidemiol. 157:1108–1114.
  • Salles GF, Cardoso CR, Muxfeldt ES. (2008). Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch. Intern. Med. 168:2340–2346.
  • Sassano P, Chatellier G, Corvol P, Ménard J. (1987). Influence of observer's expectation on the placebo effect in blood pressure trials. Curr. Ther. Res. 41:305–312.
  • Shaginian MG. (2006). Blood pressure circadian rhythms during development of hypertension in healthy pregnant women. Georgian Med. News 138:84–86.
  • Shennan A, Halligan A. (1998). Ambulatory blood pressure monitoring in pregnancy. Fetal Matern. Med. Rev. 10:69–89.
  • Sibai BM. (1988). Pitfalls in diagnosis and management of preeclampsia. Am. J. Obstet. Gynecol. 159:1–5.
  • Sibai BM, Caritis S, Hauth J. (2003). What we have learned about preeclampsia. Semin. Perinatol. 27:239–246.
  • Skjaerven R, Wilcox AJ, Lie RT. (2002). The interval between pregnancies and the risk of pre-eclampsia. N. Engl. J. Med. 346:33–38.
  • Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. (2007). Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668–680.
  • Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press. Monit. 15:173–180.
  • Smolensky MH, Siegel RA, Haus E, Hermida R, Portaluppi F. (2012). Biological rhythms, drug delivery, and chronotherapeutics. In Siepmann J, Siegel RA, Rathbone MJ (eds.). Fundamentals and applications of controlled release drug delivery. Heidelberg, Germany: Springer Verlag, 359–443.
  • Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. (2010). Pre-eclampsia. Lancet 376:631–644.
  • Sturrock NDC, George E, Pound N, Stevenson J, Peck GM, Sowter H. (2000). Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet. Med. 17:360–364.
  • Svensson A, Sigström L, Andersch B, Hansson L. (1983). Maternal hypertension during pregnancy and high blood pressure in children. Clin. Exp. Hypertens. B 2:203–209.
  • Taylor RS, Freeman L, North RA. (2001). Evaluation of ambulatory and self-initiated blood pressure monitors by pregnant and postpartum women. Hypertens. Pregnancy 20:25–33.
  • Tranquilli AL, Giannubilo SR, Dell'Uomo B, Corradetti A. (2004). Prediction of gestational hypertension or intrauterine fetal growth restriction by mid-trimester 24-h ambulatory blood pressure monitoring. Int. J. Gynaecol. Obstet. 85:126–131.
  • Trasforini G, Margutti A, Portaluppi F, Menegatti M, Ambrosio MR, Bagni B, Pansini R, degli Uberti EC. (1991). Circadian profile of plasma calcitonin gene-related peptide in healthy man. J. Clin. Endocrinol. Metab. 73:945–951.
  • Varani K, Gessi S, Caiazza A, Rastelli G, Portaluppi F, Borea PA. (1999a). Platelet alpha2-adrenoceptor alterations in patients with essential hypertension. Br. J. Clin. Pharmacol. 47:167–172.
  • Varani K, Portaluppi F, Merighi S, Ongini E, Belardinelli L, Borea PA. (1999b). Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation 99:2499–2502.
  • Varani K, Portaluppi F, Gessi S, Merighi S, Ongini E, Belardinelli L, Borea PA. (2000). Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors: functional and biochemical aspects. Circulation 102:285–289.
  • Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. (1994). Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 24:793–801.
  • Villar MA, Sibai BM. (1989). Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic blood pressure during the third trimester. Am. J. Obstet. Gynecol. 160:419–423.
  • Vollebregt KC, Gisolf J, Guelen I, Boer K, van Montfrans G, Wolf H. (2010). Limited accuracy of the hyperbaric index, ambulatory blood pressure and sphygmomanometry measurements in predicting gestational hypertension and preeclampsia. J. Hypertens. 28:127–134.
  • Vriz O, Lu H, Visentin P, Nicolosi L, Mos L, Palatini P. (1997). Gender differences in the relationship between left ventricular size and ambulatory blood pressure in borderline hypertension. The HARVEST Study. Eur. Heart J. 18:664–670.
  • Walker RL, Hemmelgarn B, Quan H. (2009). Incidence of gestational hypertension in the Calgary Health Region from 1995 to 2004. Can. J. Cardiol. 25:e284–e287.
  • Wallis AB, Saftlas AF, Hsia J, Atrash HK. (2008). Secular trends in the rates of pre-eclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am. J. Hypertens. 21:521–526.
  • Walsh SW. (1985). Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am. J. Obstet. Gynecol. 152:335–340.
  • Wang X, Poole JC, Treiber FA, Harshfield GA, Hanevold CD, Snieder H. (2006). Ethnic and gender differences in ambulatory blood pressure trajectories: results from a 15-year longitudinal study in youth and young adults. Circulation 114:2780–2787.
  • Waugh J, Perry IJ, Halligan AW, De Swiet M, Lambert PC, Penny JA, Taylor DJ, Jones DR, Shennan A. (2000). Birth weight and 24-hour ambulatory blood pressure in nonproteinuric hypertensive pregnancy. Am. J. Obstet. Gynecol. 183:633–637.
  • Wilcox J. (1961). Observer factors in the measurement of blood pressure. Nurs. Res. 10:4–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.